Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
ESC: Artificial Intelligence Can Better Assess and Diagnose Cardiac Function
08/29/2022
In a first-of-its-kind randomized clinical trial, AI proved more successful in assessing and diagnosing cardiac function when compared to echocardiogram assessments made by sonographers.
In a first-of-its-kind randomized clinical trial, AI proved more successful in assessing and diagnosing cardiac function when compared to echocardiogram assessments made by sonographers.
In a first-of-its-kind...
08/29/2022
Cath Lab Digest
News
ESC: Medtronic Extravascular ICD Meets Global Pivotal Clinical Trial’s Safety and Effectiveness Endpoints
08/29/2022
DUBLIN and BARCELONA, Spain – Aug. 29, 2022 –Medtronic plc announced that its investigational EV ICD™ System – a first-of-its-kind defibrillator with the lead placed under the breastbone, outside of the heart and veins – achieved a...
DUBLIN and BARCELONA, Spain – Aug. 29, 2022 –Medtronic plc announced that its investigational EV ICD™ System – a first-of-its-kind defibrillator with the lead placed under the breastbone, outside of the heart and veins – achieved a...
DUBLIN and BARCELONA,...
08/29/2022
Cath Lab Digest
News
ESC: New Risk Score From ENVISAGE-TAVI AF Trial Predicts Mortality for Atrial Fibrillation Patients Undergoing Transcatheter Aortic Valve Replacement
08/29/2022
Mount Sinai researchers led the international ENVISAGE-TAVI trial across 173 centers in 14 countries to compare the safety and efficacy of different therapies in AF/TAVR patients who need oral anticoagulation.
Mount Sinai researchers led the international ENVISAGE-TAVI trial across 173 centers in 14 countries to compare the safety and efficacy of different therapies in AF/TAVR patients who need oral anticoagulation.
Mount Sinai researchers led the...
08/29/2022
Cath Lab Digest

Advertisement

News
ESC: Evening Dosing of Blood Pressure Medication Not Better Than Morning Dosing
08/26/2022
TIME trial presented in a Hot Line Session at ESC Congress 2022
TIME trial presented in a Hot Line Session at ESC Congress 2022
TIME trial presented in a Hot...
08/26/2022
EP Lab Digest
News
physIQ Announces Collaboration With InCarda Therapeutics and Syneos Health to Accelerate Innovative Phase III Study in Patients With Atrial Fibrillation
08/24/2022
08/24/2022
EP Lab Digest
News
Merit Medical Launches SafeGuard Focus Cool™ Compression Device
08/24/2022
Modern design advances patient care by combining hemostasis with innovative cooling capability.
Modern design advances patient care by combining hemostasis with innovative cooling capability.
Modern design advances patient...
08/24/2022
EP Lab Digest

Advertisement

News
Vektor Medical’s Technology Attracts Seasoned MedTech Experts to Lead Sales and Quality Functions
08/24/2022
Tim Laird joins as Vice President of Sales. Kathryn Wilamowski joins as Senior Manager, Quality Systems.
Tim Laird joins as Vice President of Sales. Kathryn Wilamowski joins as Senior Manager, Quality Systems.
Tim Laird joins as Vice...
08/24/2022
EP Lab Digest
News
Thermedical Announces FDA Approval of Clinical Trial for SERF Ablation to Treat Patients with Ventricular Tachycardia, Leading Cause of Sudden Cardiac Death
08/23/2022
The U.S. FDA approved a clinical trial to evaluate the safety and efficacy of the Thermedical® SERF Ablation System with the Durablate® Catheter in people with ventricular tachycardia (VT) resistant to conventional treatment. VT is a leading...
The U.S. FDA approved a clinical trial to evaluate the safety and efficacy of the Thermedical® SERF Ablation System with the Durablate® Catheter in people with ventricular tachycardia (VT) resistant to conventional treatment. VT is a leading...
The U.S. FDA approved a clinical...
08/23/2022
EP Lab Digest
News
First-in-Human Trial Shows Promise for Hard-to-Treat Ventricular Tachycardia Heart Rhythms
08/18/2022
A first-in-human multicenter trial involving Mayo Clinic used a new ablation technique for patients with ventricular tachycardia, an abnormally rapid heart rhythm that is a leading cause of sudden cardiac death worldwide.
A first-in-human multicenter trial involving Mayo Clinic used a new ablation technique for patients with ventricular tachycardia, an abnormally rapid heart rhythm that is a leading cause of sudden cardiac death worldwide.
A first-in-human multicenter...
08/18/2022
EP Lab Digest

Advertisement

News
CathVision Announces Close of $7.2 Million Financing Round
08/17/2022
Funding Will Accelerate Commercialization of the ECGenius™ System and Expand Development of Analytic Modules.
Funding Will Accelerate Commercialization of the ECGenius™ System and Expand Development of Analytic Modules.
Funding Will Accelerate...
08/17/2022
EP Lab Digest

Advertisement

EPLD August 2024 cover.

Current Issue

August 2024
Volume 24
Issue 8
Current Issue
Issue Archive

Advertisement

Advertisement

Stay in the know.

EP Lab Digest Newsletter

Advertisement

Advertisement

Advertisement

Ahead of Print

Clinical Images
Redo Transcatheter Aortic Valve Replacement in a Young Patient With Congenital Aortic Valve Disease
08/07/2024
A 39-year-old man with Shone complex presented with acute decompensated heart failure. He had undergone 4 previous sternotomies and a 23-mm Sapien XT transcatheter aortic valve replacement for severe bioprosthetic aortic regurgitation in 2014.
A 39-year-old man with Shone complex presented with acute decompensated heart failure. He had undergone 4 previous sternotomies and a 23-mm Sapien XT transcatheter aortic valve replacement for severe bioprosthetic aortic regurgitation in 2014.
A 39-year-old man with Shone...
08/07/2024
Journal of Invasive Cardiology
Clinical Images
Redo Transcatheter Aortic Valve Replacement in a Young Patient With Congenital Aortic Valve Disease
08/07/2024
A 39-year-old man with Shone complex presented with acute decompensated heart failure. He had undergone 4 previous sternotomies and a 23-mm Sapien XT transcatheter aortic valve replacement for severe bioprosthetic aortic regurgitation in 2014.
A 39-year-old man with Shone complex presented with acute decompensated heart failure. He had undergone 4 previous sternotomies and a 23-mm Sapien XT transcatheter aortic valve replacement for severe bioprosthetic aortic regurgitation in 2014.
A 39-year-old man with Shone...
08/07/2024
Journal of Invasive Cardiology
Clinical Images
Stentectomy by an Entrapped Rotational Atherectomy Burr
08/05/2024
A 73-year-old man presented with exertional angina and anterior ischemia on stress testing. He had undergone prior coronary artery bypass surgery and multiple percutaneous coronary interventions.
A 73-year-old man presented with exertional angina and anterior ischemia on stress testing. He had undergone prior coronary artery bypass surgery and multiple percutaneous coronary interventions.
A 73-year-old man presented with...
08/05/2024
Journal of Invasive Cardiology
Clinical Images
Stentectomy by an Entrapped Rotational Atherectomy Burr
08/05/2024
A 73-year-old man presented with exertional angina and anterior ischemia on stress testing. He had undergone prior coronary artery bypass surgery and multiple percutaneous coronary interventions.
A 73-year-old man presented with exertional angina and anterior ischemia on stress testing. He had undergone prior coronary artery bypass surgery and multiple percutaneous coronary interventions.
A 73-year-old man presented with...
08/05/2024
Journal of Invasive Cardiology
Clinical Images
Calcium Is Not an Issue for Transcatheter Therapy in the Mitral Valve: The Role of Independent Leaflet Grasping
07/30/2024
A 75-year-old woman with a history of heart failure was referred for dyspnea upon exertion due to severe mitral regurgitation.
A 75-year-old woman with a history of heart failure was referred for dyspnea upon exertion due to severe mitral regurgitation.
A 75-year-old woman with a...
07/30/2024
Journal of Invasive Cardiology

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use